Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification

Bibliografske podrobnosti
Main Authors:	Seymour, M, Brown, SR, Richman, S, Middleton, G, Maughan, T, Maisey, N, Hill, M, Olivier, C, Napp, V, Quirke, P
Format:	Conference item
Izdano:	2011

Podobne knjige/članki

Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer - Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
od: Middleton, G, et al.
Izdano: (2011)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.
od: Seymour, M, et al.
Izdano: (2013)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): A prospectively stratified randomised trial
od: Seymour, M, et al.
Izdano: (2013)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
od: Middleton, G, et al.
Izdano: (2013)

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan and Ciclosporin in COLOrectal cancer therapy trial (PICCOLO).
od: Middleton, G, et al.
Izdano: (2013)

Chemoresistance and metastasis in colorectal cancer
od: Wong, Stephen Qi Rong
Izdano: (2022)

Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
od: Moe, M, et al.
Izdano: (2008)

Capecitabine/irinotecan combination regimens in colorectal cancer.
od: Kerr, D
Izdano: (2002)

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer.
od: Sabharwal, A, et al.
Izdano: (2010)

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials
od: Seligmann, JF, et al.
Izdano: (2016)

Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials.
od: Kerr, D
Izdano: (2002)

Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
od: Alderdice, M, et al.
Izdano: (2018)

Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
od: Wachsberger, P, et al.
Izdano: (2009)

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.
od: Rea, D, et al.
Izdano: (2005)

Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment.
od: Kerr, D
Izdano: (2008)

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials.
od: Folprecht, G, et al.
Izdano: (2008)

Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions
od: Cheng, W, et al.
Izdano: (2025)

A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
od: Glynne-Jones, R, et al.
Izdano: (2007)

Mechanisms of microenvironmental paracrine signaling in cancer chemoresistance
od: Bent, Eric Huttenlocher
Izdano: (2016)

Experimental Study Of The Effect Of Piccolo Tube Pipe On The Air-Conditioning Experimental Rig
od: Ismail, Mohd Azmi
Izdano: (2019)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
od: Seymour, M, et al.
Izdano: (2011)

Error-prone translesion synthesis mediates acquired chemoresistance
od: Xie, Kun, et al.
Izdano: (2014)

DNA Damage-Mediated Induction of a Chemoresistant Niche
od: Gilbert, Luke Andrew, et al.
Izdano: (2015)

Experimental Study Of The Effect Of Piccolo Tube Pipe On The Air-Conditioning Experimental Rig Humidity
od: Sobri, Ammar Solehi Ahmad
Izdano: (2018)

Experimental Study Of The Effect Of Piccolo Tube Pipe On The Air-Conditioning Experimental Rig Humidity
od: Ahmad Sobri, Ammar Solehi
Izdano: (2018)

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial.
od: Maughan, T, et al.
Izdano: (2003)

Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.
od: Smith, C, et al.
Izdano: (2013)

Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance
od: van Gastel, Nick, et al.
Izdano: (2021)

Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance
od: van Gastel, Nick, et al.
Izdano: (2022)

Shedding Light on Chemoresistance: The Perspective of Photodynamic Therapy in Cancer Management
od: Viana Cabral, Fernanda, et al.
Izdano: (2024)

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan.
od: Midgley, R, et al.
Izdano: (2007)

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
od: Adams, R, et al.
Izdano: (2017)

Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles
od: Valencia, Pedro M, et al.
Izdano: (2015)

A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
od: Markham, C, et al.
Izdano: (2003)

Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification
od: Kleeman, S, et al.
Izdano: (2019)

Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors
od: Xin, Bernadette Jie Tune, et al.
Izdano: (2022)

BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance
od: Ferretti, Roberta, et al.
Izdano: (2017)

DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme
od: Kitange, Gaspar J., et al.
Izdano: (2016)

Investigation of the effects of IGF-1 receptor blockade on chemoresistance of advanced melanoma
od: Ramcharan, R, et al.
Izdano: (2014)

Capecitabine/irinotecan in coloreetal cancer: European early-phase data and planned trials
od: Kerr, D
Izdano: (2002)